Neumora Shares Plummet After Depression Drug Trial Fails
Neumora Therapeutics Inc. faces a setback as its depression drug, navacaprant, fails in a critical final-stage study, causing a sharp decline in shares.
Neumora Therapeutics Inc.'s shares fell dramatically after their depression drug, navacaprant, failed to show benefits in a crucial final-stage study.